0 items USD 0.00Search
- Did you mean
- crown diseases
Your search for "crohn diseases" gave back 100611 results.
The global market for Intercellular Adhesion Molecule 1 was estimated to be worth US$ million in 2023 and is forecast to a readjusted size of US$...
°ä²¹³Ù²¹±ô´Ç²µ:Ìý
MRRPB5
September 2024
Price: USD 3,950.00
The global market for Atypical Chemokine Receptor 3 was estimated to be worth US$ million in 2023 and is forecast to a readjusted size of US$ million...
°ä²¹³Ù²¹±ô´Ç²µ:Ìý
MRRPB5
September 2024
Price: USD 3,950.00
The global market for Non-corticosteroid Immunomodulator was valued at US$ 1780 million in the year 2024 and is projected to reach a revised size of...
°ä²¹³Ù²¹±ô´Ç²µ:Ìý
MRRPB5
January 2025
Price: USD 2,900.00
A TNF inhibitor is a pharmaceutical drug that suppresses the physiologic response to tumor necrosis factor (TNF), which is part of the inflammatory...
°ä²¹³Ù²¹±ô´Ç²µ:Ìý
MRRPB5
June 2023
Price: USD 4,900.00
The global Prednisolone market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the...
°ä²¹³Ù²¹±ô´Ç²µ:Ìý
MRRPB5
May 2024
Price: USD 2,900.00
The primary types of non-corticosteroid immunomodulators include, calcineurin inhibitors, antiproliferative agents, mTOR inhibitors, and IMDH...
°ä²¹³Ù²¹±ô´Ç²µ:Ìý
MRRPB5
May 2024
Price: USD 2,900.00
Highlights The global Prednisolone market was valued at US$ million in 2022 and is anticipated to reach US$ million by 2029, witnessing a CAGR of %...
°ä²¹³Ù²¹±ô´Ç²µ:Ìý
MRRPB5
April 2023
Price: USD 2,900.00
Highlights The global Intercellular Adhesion Molecule 1 market was valued at US$ million in 2022 and is anticipated to reach US$ million by 2029,...
°ä²¹³Ù²¹±ô´Ç²µ:Ìý
MRRPB5
March 2023
Price: USD 2,900.00
The global Infliximab Biosimilar market was valued at US$ million in 2022 and is anticipated to reach US$ million by 2029, witnessing a CAGR of %...
°ä²¹³Ù²¹±ô´Ç²µ:Ìý
MRRPB5
March 2023
Price: USD 2,900.00
The global Gusperimus market was valued at US$ million in 2022 and is anticipated to reach US$ million by 2029, witnessing a CAGR of % during the...
°ä²¹³Ù²¹±ô´Ç²µ:Ìý
MRRPB5
February 2023
Price: USD 2,900.00
Adalimumab is a tumor necrosis factor (TNF) blocker that reduces the effects of a substance in the body that can cause inflammation. The global...
°ä²¹³Ù²¹±ô´Ç²µ:Ìý
MRRPB5
November 2024
Price: USD 3,950.00
Capsule endoscope is an ingestible capsule which measures pH, temperature, and pressure as it passes to the gastrointestinal tract to access GI...
°ä²¹³Ù²¹±ô´Ç²µ:Ìý
MRRPB5
December 2024
Price: USD 4,900.00
Formaldehyde Dehydrogenase - Pipeline Review, H2 2019 Summary According to the recently published report 'Formaldehyde Dehydrogenase - Pipeline...
°ä²¹³Ù²¹±ô´Ç²µ:Ìý
Global Â鶹Դ´s Direct
December 2019
Price: USD 3,500.00
The global Ulcerative Colitis Immunology Drugs market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a...
°ä²¹³Ù²¹±ô´Ç²µ:Ìý
MRRPB5
August 2024
Price: USD 2,900.00
Adalimumab is a tumor necrosis factor (TNF) blocker that reduces the effects of a substance in the body that can cause inflammation. The global...
°ä²¹³Ù²¹±ô´Ç²µ:Ìý
MRRPB5
November 2024
Price: USD 3,950.00
Ìý
Filter By Report Date
Filter By Industry
Filter By Country
- Global (100164) Apply Global filter
- BRIC (2) Apply BRIC filter
- Asia (1) Apply Asia filter
- Caribbean (1) Apply Caribbean filter
- Emerging Â鶹Դ´s (1) Apply Emerging Â鶹Դ´s filter
- G8 (1) Apply G8 filter
- Korea (1) Apply Korea filter
- Latin America (1) Apply Latin America filter
- Oceania (1) Apply Oceania filter
